Archives

by in
Entry Author Date Location
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Clarus Ventures Adjusts to Unpredictable Biotech World 01/20/12 Boston
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs 01/19/12 New York
The Top 10 Traffic-Getting Stories at Xconomy San Diego 12/28/11 San Diego
Burrill Raises $313M for New Life Sciences Fund 12/19/11 San Francisco
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug 12/06/11 Seattle
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge 11/08/11 Boston
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News 11/03/11 San Diego
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again 10/27/11 Boston
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News 10/20/11 San Diego
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M 10/17/11 San Diego
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C 09/22/11 Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva 09/15/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Kineta Adds $2.8M Grant 08/16/11 Seattle
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut 07/28/11 Boston
J&J Joins Pharmasset for Hepatitis Study 07/06/11 New York
Vertex Adds New HepC Drugs for $60M 06/13/11 Boston
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News 05/26/11 San Diego
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug 05/23/11 Boston
Page 2 of 8 « previous page · next page »